financetom
Business
financetom
/
Business
/
RIL AGM: Mukesh Ambani proposes to spin off the oil-to-chemicals business into a separate entity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RIL AGM: Mukesh Ambani proposes to spin off the oil-to-chemicals business into a separate entity
Jul 15, 2020 6:20 AM

Addressing shareholders at the company's 43rd AGM, Mukesh Ambani said RIL will spin off the oil-to-chemicals (O2C) business into a separate entity and induct strategic partners.

Share Market Live

NSE

'Will approach NCLT with our proposal to spin off our O2C biz into a separate subsidiary,' Ambani announced.

The oil-to-chemical business has outperformed in a challenging environment, he said, adding that this accounted for 50 percent of India's export. He further announced that RIL has been approached by strategic investors in its petrochemicals business.

Taking about the Saudi Aramco deal, he informed that due to unforeseen circumstances and COVID 19, the deal with Saudi Aramco has not progressed as per the earlier timeline.

Mukesh Ambani further said that the company has received interest from strategic and financial investors to invest in Reliance Retail and he would induct global and strategic partners into the business.

Click here for all live updates from RIL AGM

Disclosure: Network18, the parent company of CNBCTV18.com, is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

First Published:Jul 15, 2020 3:20 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
May 15, 2024
(Reuters) - Pfizer ( PFE ) has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financial Times reported on Thursday. ...
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
May 15, 2024
May 16 (Reuters) - Pfizer ( PFE ) has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financial Times reported on Thursday. ...
PRESS DIGEST- Financial Times - May 16
PRESS DIGEST- Financial Times - May 16
May 15, 2024
May 16 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - UBS chief Sergio Ermotti criticises Swiss regulators over Credit Suisse - Eurostar plans up to 50 new trains and more services to tap 'huge' demand - Glencore ( GLCNF ) chief...
China's Nio launches Onvo brand to challenge Tesla's best-selling model
China's Nio launches Onvo brand to challenge Tesla's best-selling model
May 15, 2024
SHANGHAI/SINGAPORE, May 15 (Reuters) - Chinese electric vehicle maker Nio on Wednesday launched the first vehicle in its new lower-priced brand Onvo which aims to compete there with Tesla's Model Y, the world's best-selling EV. Nio unveiled the Onvo L60 SUV with a sticker price starting from 219,900 yuan ($30,476), 12% below the price of Tesla's Model Y which starts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved